{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T04:11:45Z","timestamp":1751688705319,"version":"3.41.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.reumae.2025.501895","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T11:58:19Z","timestamp":1751025499000},"page":"501895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology"],"prefix":"10.1016","volume":"21","author":[{"given":"Alejandro","family":"Balsa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Seoane-Mato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Dom\u00ednguez-\u00c1lvaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Alperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Ruiz-Esquide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Bachiller-Corral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"D\u00edaz-Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reumae.2025.501895_bib0005","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1586\/17512433.2015.1061429","article-title":"Remission in rheumatoid arthritis: is it all the same?","volume":"8","author":"Gul","year":"2015","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.reumae.2025.501895_bib0010","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/art.22619","article-title":"Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort","volume":"57","author":"Khanna","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501895_bib0015","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1136\/ard.2004.034371","article-title":"Comparison of different definitions to classify remission and sustained remission: 1 year TEMPO results","volume":"64","author":"van der Heijde","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2025.501895_bib0020","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/rheumatology\/kep442","article-title":"Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard","volume":"49","author":"Balsa","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2025.501895_bib0025","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/ard.2011.149765","article-title":"American College of Rheumatology\/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials","volume":"70","author":"Felson","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501895_bib0030","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1093\/rheumatology\/ker425","article-title":"The provisional ACR\/EULAR definition of remission in RA: a comment on the patient global assessment criterion","volume":"51","author":"Vermeer","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.reumae.2025.501895_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard-2022-223413","article-title":"American College of Rheumatology\/EULAR remission criteria for rheumatoid arthritis: 2022 revision","volume":"82","author":"Studenic","year":"2023","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2025.501895_bib0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/acr.23284","article-title":"Suppressing inflammation in rheumatoid arthritis: does patient global assessment blur the target? A practice-based call for a paradigm change","volume":"70","author":"Ferreira","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reumae.2025.501895_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003972","article-title":"Remission definitions guiding immunosuppressive therapy in rheumatoid arthritis: which is best fitted for the purpose?","volume":"10","author":"Duarte","year":"2024","journal-title":"RMD Open."},{"key":"10.1016\/j.reumae.2025.501895_bib0050","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00296-018-4005-5","article-title":"Call for action: how to improve use of patient-reported outcomes to guide clinical decision making in rheumatoid arthritis","volume":"38","author":"Fautrel","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.reumae.2025.501895_bib0055","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.semarthrit.2021.07.010","article-title":"Considerations and priorities for incorporating the patient perspective on remission in rheumatoid arthritis: An OMERACT 2020 special interest group report","volume":"51","author":"Jones","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501895_bib0060","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2021-002093","article-title":"Patient reported outcome measures for rheumatoid arthritis disease activity: a systematic review following COSMIN guidelines","volume":"8","author":"Pickles","year":"2022","journal-title":"RMD Open"},{"author":"Cohen","key":"10.1016\/j.reumae.2025.501895_bib0065"},{"key":"10.1016\/j.reumae.2025.501895_bib0070","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/CM9.0000000000000811","article-title":"Effect of sustained intensive therapy with disease modifying anti-rheumatic drugs in rheumatoid arthritis: a 5-year real-world consecutive study","volume":"133","author":"Cai","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.reumae.2025.501895_bib0075","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X221096363","article-title":"Comparison of remission criteria in patients with rheumatoid arthritis treated with biologic or targeted synthetic disease-modifying anti-rheumatic drugs: results from a nationwide registry","volume":"14","author":"Koh","year":"2022","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.reumae.2025.501895_bib0080","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/acr.23873","article-title":"Sex differences in the achievement of remission and low disease activity in rheumatoid arthritis","volume":"72","author":"Maynard","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.reumae.2025.501895_bib0085","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s10067-019-04654-7","article-title":"Predictors and the optimal duration of sustained remission in rheumatoid arthritis","volume":"38","author":"Yilmaz-Oner","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501895_bib0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10067-018-4340-7","article-title":"Remission rate and predictors of remission in patients with rheumatoid arthritis under treat-to-target strategy in real-world studies: a systematic review and meta-analysis","volume":"38","author":"Yu","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.reumae.2025.501895_bib0095","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1002\/art.1780350502","article-title":"The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis","volume":"35","author":"Hochberg","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.reumae.2025.501895_bib0100","first-page":"2116","article-title":"Spanish version of the Health Assessment Questionnaire (HAQ): reliability, validity and transcultural equivalency. Grupo para la Adaptaci\u00f3n del HAQ a la Poblaci\u00f3n Espa\u00f1ola","volume":"20","author":"Esteve-Vives","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.reumae.2025.501895_bib0105","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/ard.2010.142901","article-title":"Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative","volume":"70","author":"Gossec","year":"2011","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.reumae.2025.501895_bib0110","doi-asserted-by":"crossref","DOI":"10.1186\/ar3141","article-title":"Validity of the work productivity and activity impairment questionnaire--general health version in patients with rheumatoid arthritis","volume":"12","author":"Zhang","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.reumae.2025.501895_bib0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11547-019-01002-2","article-title":"Ultrasound imaging in rheumatoid arthritis","volume":"124","author":"Filippucci","year":"2019","journal-title":"Radiol Med."},{"key":"10.1016\/j.reumae.2025.501895_bib0120","first-page":"2485","article-title":"Musculoskeletal ultrasound including definitions for ultrasonographic pathology","volume":"32","author":"Wakefield","year":"2005","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reumae.2025.501895_bib0125","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1002\/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO;2-K","article-title":"Validation of rheumatoid arthritis improvement criteria that include simplified joint counts","volume":"41","author":"Van Gestel","year":"1998","journal-title":"Arthritis Rheum."},{"year":"2013","author":"Hosmer","series-title":"Applied logistic regression","key":"10.1016\/j.reumae.2025.501895_bib0130"},{"key":"10.1016\/j.reumae.2025.501895_bib0135","first-page":"1674","article-title":"Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy","volume":"34","author":"Wolfe","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1016\/j.reumae.2025.501895_bib0140","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/annrheumdis-2019-216529","article-title":"Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR\/EULAR Boolean criteria optimal?","volume":"79","author":"Studenic","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.reumae.2025.501895_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/rai2.12006","article-title":"Subclinical synovitis detected by magnetic resonance imaging and ultrasonography following clinical remission in patients with rheumatoid arthritis: a retrospective study","volume":"1","author":"Nawata","year":"2021","journal-title":"Rheumatol Autoimmun."},{"key":"10.1016\/j.reumae.2025.501895_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03009742.2019.1637932","article-title":"Validation and assessment of minimally clinically important difference of the unadjusted Health Assessment Questionnaire in a Danish cohort: uncovering ordinal bias","volume":"49","author":"\u00d8rnbjerg","year":"2020","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.reumae.2025.501895_bib0155","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3899\/jrheum.080479","article-title":"The minimally important difference for the health assessment questionnaire in rheumatoid arthritis clinical practice is smaller than in randomized controlled trials","volume":"36","author":"Pope","year":"2009","journal-title":"J Rheumatol."}],"container-title":["Reumatolog\u00eda Cl\u00ednica (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432500084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S217357432500084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T17:44:52Z","timestamp":1751651092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S217357432500084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S217357432500084X"],"URL":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501895","relation":{},"ISSN":["2173-5743"],"issn-type":[{"type":"print","value":"2173-5743"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study of the impact of the inclusion of global pain and functional capacity assessment in the definition of remission and its maintenance for rheumatoid arthritis. Aims and methodology","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reumae.2025.501895","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2025.501895","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Reumatolog\u00eda (SER), Colegio Mexicano de Reumatolog\u00eda (CMR) and Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501895"}}